Division of Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Nat Commun. 2022 Sep 8;13(1):5167. doi: 10.1038/s41467-022-32861-5.
Protection of stalled replication forks is essential to prevent genome instability, a major driving force of tumorigenesis. Several key regulators of DNA double-stranded break (DSB) repair, including 53BP1 and RIF1, have been implicated in fork protection. MAD2L2, also known as REV7, plays an important role downstream of 53BP1/RIF1 by counteracting resection at DSBs in the recently discovered shieldin complex. The ability to bind and counteract resection at exposed DNA ends at DSBs makes MAD2L2/shieldin a prime candidate for also suppressing nucleolytic processing at stalled replication forks. However, the function of MAD2L2/shieldin outside of DNA repair is unknown. Here we address this by using genetic and single-molecule analyses and find that MAD2L2 is required for protecting and restarting stalled replication forks. MAD2L2 loss leads to uncontrolled MRE11-dependent resection of stalled forks and single-stranded DNA accumulation, which causes irreparable genomic damage. Unexpectedly, MAD2L2 limits resection at stalled forks independently of shieldin, since fork protection remained unaffected by shieldin loss. Instead, MAD2L2 cooperates with the DNA polymerases REV3L and REV1 to promote fork stability. Thus, MAD2L2 suppresses aberrant nucleolytic processing both at DSBs and stalled replication forks by differentially engaging shieldin and REV1/REV3L, respectively.
复制叉停滞的保护对于防止基因组不稳定性至关重要,而基因组不稳定性是肿瘤发生的主要驱动力。几种 DNA 双链断裂 (DSB) 修复的关键调节剂,包括 53BP1 和 RIF1,已被牵连到叉保护中。MAD2L2,也称为 REV7,通过在最近发现的屏蔽复合物中拮抗 DSB 处的切除,在 53BP1/RIF1 的下游发挥重要作用。MAD2L2/屏蔽复合物在暴露的 DNA 末端结合并拮抗切除的能力使其成为抑制停滞复制叉核酶加工的主要候选物。然而,MAD2L2/屏蔽复合物在 DNA 修复之外的功能尚不清楚。在这里,我们通过遗传和单分子分析来解决这个问题,发现 MAD2L2 对于保护和重新启动停滞的复制叉是必需的。MAD2L2 的缺失导致失控的 MRE11 依赖性停滞叉的切除和单链 DNA 的积累,这会导致不可修复的基因组损伤。出乎意料的是,MAD2L2 限制了停滞叉的切除,独立于屏蔽复合物,因为屏蔽复合物的缺失对叉保护没有影响。相反,MAD2L2 与 DNA 聚合酶 REV3L 和 REV1 合作,促进叉的稳定性。因此,MAD2L2 通过分别与屏蔽复合物和 REV1/REV3L 结合,抑制 DSB 和停滞复制叉处异常的核酶加工。